Connor, Clark & Lunn Investment Management (CC&L)
MD icon

Connor, Clark & Lunn Investment Management (CC&L)’s Pediatrix Medical MD Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,811
Closed -$595K – 1730
2026
Q1 		$595K Sell
27,811
-80,727
-74% -$1.68M ﹤0.01% 1282
2025
Q4 		$2.32M Sell
108,538
-109,875
-50% -$2.25M 0.01% 888
2025
Q3 		$3.66M Buy
218,413
+42,426
+24% +$636K 0.01% 672
2025
Q2 		$2.53M Buy
175,987
+130,226
+285% +$1.79M 0.01% 791
2025
Q1 		$663K Sell
45,761
-39,997
-47% -$568K ﹤0.01% 1070
2024
Q4 		$1.13M Sell
85,758
-177,652
-67% -$2.45M 0.01% 891
2024
Q3 		$3.05M Buy
263,410
+99,324
+61% +$937K 0.01% 564
2024
Q2 		$1.24M Buy
164,086
+57,412
+54% +$475K 0.01% 803
2024
Q1 		$1.07M Sell
106,674
-18,222
-15% -$170K ﹤0.01% 864
2023
Q4 		$1.16M Sell
124,896
-79,629
-39% -$824K 0.01% 821
2023
Q3 		$2.6M Buy
204,525
+43,440
+27% +$596K 0.01% 547
2023
Q2 		$2.29M Buy
161,085
+122,536
+318% +$1.72M 0.01% 576
2023
Q1 		$575K Buy
+38,549
New +$584K ﹤0.01% 845
2022
Q4 		– Sell
-75,504
Closed -$1.25M – 1347
2022
Q3 		$1.25M Buy
+75,504
New +$1.52M 0.01% 603
2020
Q3 		– Sell
-127,033
Closed -$2.17M – 1041
2020
Q2 		$2.17M Sell
127,033
-166,136
-57% -$2.46M 0.02% 443
2020
Q1 		$3.41M Sell
293,169
-54,175
-16% -$1.12M 0.03% 314
2019
Q4 		$9.65M Buy
347,344
+51,908
+18% +$1.3M 0.07% 187
2019
Q3 		$6.68M Buy
295,436
+147,536
+100% +$3.36M 0.05% 222
2019
Q2 		$3.73M Buy
147,900
+138,050
+1,402% +$3.71M 0.02% 334
2019
Q1 		$268K Buy
+9,850
New +$330K ﹤0.01% 774
2014
Q4 		– Sell
-6,200
Closed -$340K – 617
2014
Q3 		$340K Buy
+6,200
New +$352K ﹤0.01% 436

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s MD Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Pediatrix Medical (MD) in Q2 2026, closing a stake of 27,811 shares — an estimated $595K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in MD in Q3 2014 and held it in 21 quarters. The position peaked at $9.65M in Q4 2019. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Pediatrix Medical position as of Q2 2026 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 27,811 Pediatrix Medical shares in Q2 2026, an estimated $595K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Pediatrix Medical in Q3 2014 and held it in 21 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Pediatrix Medical position peaked at $9.65M in Q4 2019.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.